Literature DB >> 29133246

Potentially inappropriate liver transplantation in the era of the "sickest first" policy - A search for the upper limits.

Michael Linecker1, Tanja Krones2, Thomas Berg3, Claus U Niemann4, Randolph H Steadman5, Philipp Dutkowski1, Pierre-Alain Clavien1, Ronald W Busuttil6, Robert D Truog7, Henrik Petrowsky8.   

Abstract

Liver transplantation has emerged as a highly efficient treatment for a variety of acute and chronic liver diseases. However, organ shortage is becoming an increasing problem globally, limiting the applicability of liver transplantation. In addition, potential recipients are becoming sicker, thereby increasing the risk of losing the graft during transplantation or in the initial postoperative period after liver transplantation (three months). This trend is challenging the model for end-stage liver disease allocation system, where the sickest candidates are prioritised and no delisting criteria are given. The weighting of the deontological demand for "equity", trying to save every patient, regardless of the overall utility; and "efficiency", rooted in utilitarianism, trying to save as many patients as possible and increase the overall quality of life of patients facing the same problem, has to be reconsidered. In this article we are aiming to overcome the widespread concept of futility in liver transplantation, providing a definition of potentially inappropriate liver transplantation and giving guidance on situations where it is best not to proceed with liver transplantation, to decrease the mortality rate in the first three months after transplantation. We propose "absolute" and "relative" conditions, where early post-transplant mortality is highly probable, which are not usually captured in risk scores predicting post-transplant survival. Withholding liver transplantation for listed patients in cases where liver transplant is not deemed clearly futile, but is potentially inappropriate, is a far-reaching decision. Until now, this decision had to be discussed extensively on an individual basis, applying explicit communication and conflict resolution processes, since the model for end-stage liver disease score and most international allocation systems do not include explicit delisting criteria to support a fair delisting process. More work is needed to better identify cases where transplantation is potentially inappropriate and to integrate and discuss these delisting criteria in allocation systems, following a societal debate on what we owe to all liver transplant candidates.
Copyright © 2017 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ACLF; ALF; CLF; Efficiency; Equity; Futile; Liver transplant; Organ shortage

Mesh:

Year:  2017        PMID: 29133246     DOI: 10.1016/j.jhep.2017.11.008

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  9 in total

1.  Short- and Long-Term Outcomes After Live-Donor Transplantation with Hyper-Reduced Liver Grafts in Low-Weight Pediatric Recipients.

Authors:  Micaela Raices; Matias Eduardo Czerwonko; Victoria Ardiles; Gustavo Boldrini; Daniel D'Agostino; José Marcó Del Pont; Juan Pekolj; Juan Mattera; Claudio Brandi; Miguel Ciardullo; Eduardo de Santibañes; Martin de Santibañes
Journal:  J Gastrointest Surg       Date:  2019-03-18       Impact factor: 3.452

Review 2.  Should Sarcopenia Increase Priority for Transplant or Is It a Contraindication?

Authors:  Guido Stirnimann; Maryam Ebadi; Puneeta Tandon; Aldo J Montano-Loza
Journal:  Curr Gastroenterol Rep       Date:  2018-09-26

3.  A nomogram to predict survival in patients with acute-on-chronic hepatitis B liver failure after liver transplantation.

Authors:  Liang Chen; Jiebin Zhang; Tongyu Lu; Jianye Cai; Jun Zheng; Jia Yao; Shuhong Yi; Hua Li; Guihua Chen; Hui Zhao; Yingcai Zhang; Yang Yang
Journal:  Ann Transl Med       Date:  2021-04

Review 4.  Approaches for patients with very high MELD scores.

Authors:  Florent Artru; Didier Samuel
Journal:  JHEP Rep       Date:  2019-02-23

Review 5.  Invasive fungal infection before and after liver transplantation.

Authors:  Alberto Ferrarese; Annamaria Cattelan; Umberto Cillo; Enrico Gringeri; Francesco Paolo Russo; Giacomo Germani; Martina Gambato; Patrizia Burra; Marco Senzolo
Journal:  World J Gastroenterol       Date:  2020-12-21       Impact factor: 5.742

Review 6.  Progress of Interference of Traditional Chinese Medicine on Cirrhosis Treated with Bone Marrow Mesenchymal Stem Cells.

Authors:  Yaxin Wang; Huicun Zhang; Hongbing Wang
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-11       Impact factor: 2.629

7.  From hair to liver: emerging application of hair follicle mesenchymal stem cell transplantation reverses liver cirrhosis by blocking the TGF-β/Smad signaling pathway to inhibit pathological HSC activation.

Authors:  Qi Liu; Chengqian Lv; Yanan Jiang; Kunpeng Luo; Yang Gao; Jingyang Liu; Xu Zhang; Jan Mohammad Omar; Shizhu Jin
Journal:  PeerJ       Date:  2022-02-15       Impact factor: 2.984

8.  Creatinine-lactate score predicts mortality in non-acetaminophen-induced acute liver failure in patients listed for liver transplantation.

Authors:  Estela Regina Ramos Figueira; Joel Avancini Rocha-Filho; Cinthia Lanchotte; Lucas Souto Nacif; Luciana Bertocco de Paiva Haddad; Adriana Rochetto Assalin; Yumi Ricucci Shinkado; Agustin Moscoso Vintimilla; Flavio Henrique Ferreira Galvao; Luiz Augusto Carneiro D'Albuquerque
Journal:  BMC Gastroenterol       Date:  2021-06-07       Impact factor: 3.067

9.  The Graz Liver Allocation Strategy-Impact of Extended Criteria Grafts on Outcome Considering Immunological Aspects.

Authors:  Judith Kahn; Gudrun Pregartner; Alexander Avian; Daniela Kniepeiss; Helmut Müller; Peter Schemmer
Journal:  Front Immunol       Date:  2020-08-04       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.